Cell Cycle and Transcriptional Control of Human Myeloid Leukemic Cells by Transforming Growth Factor Beta

References

• Masui T, Wakefield L M, Lechner J F, LaVeck M A, Spom M B, Harris C C. Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc Natl Acad Sci USA 1986; 83: 2438–2442
   PubMed Web of Science ®Google Scholar
• Manning A M, Williams A C, Game S M, Paraskeva C. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF-beta): conversion of an adenoma cell line to a tumorigenic pheno-type is accompanied by a reduced response to the inhibitory effects of TGF-beta. Oncogene 1991; 6: 1471–1476
   PubMed Web of Science ®Google Scholar
• Assoian R K, Komoriya A, Meyers C A, Miller D M, Spom M B. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem. 1983; 258: 7155–7160
   PubMed Web of Science ®Google Scholar
• Derynck R, Lindguist P B, Lee A, Wen D, Tamm J. A new type of transforming growth factor-beta, TGF-beta 3. EMBO J 1988; 7: 3737–43
   PubMed Web of Science ®Google Scholar
• TenDijke P, Hansen P, Iwata K K, Pieler C, Foulkes J G. Identification of another member of the transforming growth factor type beta gene family. Proc. Natl. Acad. Sci. USA 1988; 85: 4715–4719
   PubMed Web of Science ®Google Scholar
• Jakowlew S B, Dillard P J, Kondiah P, Sporn M B, Roberts A B. Complementary deoxyribonucleic acid cloning of a novel transforming growth factor-beta messenger ribonucleic acid from chick embryo chondrocytes. Mol Endocrinol 1988; 2: 747–755
   PubMed Web of Science ®Google Scholar
• Jakowlew S B, Dillard P J, Kondiah P, Sporn M B, Roberts A B. Complementary deoxyribonucleic acid cloning of a messenger ribonucleic acid encoding transforming growth factor beta 4 from chicken embryo chondrocytes. Mol Endocrinol 1988; 1186–1195
   PubMed Web of Science ®Google Scholar
• Frolik C A, Dart L L, Meyers C A, Smith D M, Sporn M B. Purification and initial characterization of a type beta transforming growth factor from human placenta. Proc Natl Acad Sci USA 1983; 80: 3676–3680
   PubMed Web of Science ®Google Scholar
• Roberts A B, Anzano M A, Meyers C A, Wideman J, Blacher R. Purification and properties of a type beta transforming growth factor from bovine kidney. Biochemistry 1983; 22: 5692–5698
   PubMed Web of Science ®Google Scholar
• Laiho M, DcCaprio J A, Ludlow J W, Livingston D M, Massague J. Growth inhibition by TGFβ linked to suppression of retinoblastoma protein phosphorylation. Cell 1990; 62: 175–185
   PubMed Web of Science ®Google Scholar
• Furukawa Y, Uenoyama S, Ohta M, Tsunoda A, Griffin J D, Saito M. Transforming growth factor-beta inhibits phosphorylation of the retinoblastoma susceptibility gene product in human monocytic leukemia cell line JOSK-I. J Biol Chem, 267: 17121–1992
   PubMed Web of Science ®Google Scholar
• Howe P H, Dractta G, Leof E B. Transforming growth factor beta 1 inhibition of p34cdc2 phosphorylation and his-tone HI kinase activity is associated with G1/S-phase growth arrest. Mol Cell Biol 1991; 11: 1185–1194
   PubMed Web of Science ®Google Scholar
• Pietenpol J A, Stein R W, Moran E, Yaciuk P, Schlegel R, Lyons R M, Pittelkow M R, Munger K, Howley P M, Moses H L. TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 1990; 61: 777–785
   PubMed Web of Science ®Google Scholar
• Shipley G D, Tucker R F, Moses H L. Type β transforming growth factor/growth inhibitor stimulates entry of monolayer cultures of AKR-2B cells into S phase after a prolonged pre-replicative interval. Proc. Natl Acad. Sci USA 1995; 82: 4147–4151
   Web of Science ®Google Scholar
• Geng Y, Weinberg R A. Transforming growth factor beta effect on expression of G1 cyclins and cycli-dependent protein kinases. Proc. Natl. Acad. Sci. USA 1993; 90: 10315–10319
   PubMed Web of Science ®Google Scholar
• Koff A, Ohtsuki M, Polyak K, Roberts J M, Massague J. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta. Science 1993; 260: 536–539
   PubMed Web of Science ®Google Scholar
• Ewen M E, Sluss H K, Whitehouse L L, Livingston D M. TGF beta inhibition of cdk4 synthesis is linked to cell cycle arrest. cell 1993; 74: 1009–1020
   PubMed Web of Science ®Google Scholar
• Slingerland J M, Hengst L, Pan C-H, Alexander D, Stampfer M R, Reed S I. A novel inhibitor of cyclin-cdk activity detected in transforming growth factor beta-arrested epithelial cells. Mol. Cell. Biol. 1994; 14: 3683–3694
   PubMed Web of Science ®Google Scholar
• Pietenpol J A, Holt J T, Stein R W, Moses H L. Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. Proc. Natl. Acad. Sci USA 1990; 87: 3758–3762
   PubMed Web of Science ®Google Scholar
• Inaba T, Matsushime H, Valentine M, Roussel M F, Sherr C J, Look A T. Genomic organization, chromosomal localization, and independent expression of human cyclin D genes. Genomics 1992; 13: 565–574
   PubMed Web of Science ®Google Scholar
• Kiyokawa H, Busquets X, Powell C T, Ngo L, Rifkind R A, Marks P A. Cloning of a D-type cyclin from murine erythroleukemia cells. Proc Natl. Acad. Sci. USA 1992; 89: 2444–2447
   PubMed Web of Science ®Google Scholar
• Koff A, Cross F, Fisher A, Schumacher J, Leguellec K, Philippe M, Roberts J M. Human cyclin E, a new cylin that interacts with two members of the CDC2 gene family. Cell 1991; 66: 1217–1228
   PubMed Web of Science ®Google Scholar
• Lew D J, Dulic V, Reed S I. Isolation of three novel human cyclins by rescue of Gl cyclin (CLn) function in yeast. Cell 1991; 66: 1197–1206
   PubMed Web of Science ®Google Scholar
• Matsushime H, Roussel M F, Ashmun R A, Sherr C J. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 1991; 65: 701–713
   PubMed Web of Science ®Google Scholar
• Motokura T, Bloom T, Kim H G, Juppner H, Ruderman J V, Kronenberg H M, Arnold A, Motokura T, Keyomarsi K, Kronenberg H M, Arnold A. Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1/cyclin Dl proto-oncogene. J. Biol. Chem. 1992; 267: 20412–20415
   PubMed Web of Science ®Google Scholar
• Xiong Y, Connolly T, Futcher B, Beach D. Human D-type cyclin. Cell 1991; 65: 691–699
   PubMed Web of Science ®Google Scholar
• Bates S, Bonetta L, MacAllan D, Parry D, Holder A, Dickson C, Peters G. Cdk6 (PLSTIRE) and cdk4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin Dl. Oncogene 1994; 9: 71–79
   PubMed Web of Science ®Google Scholar
• Dou Q-P, Levin A H, Zhao S, Pardee A B. Cyclin E and cyclin A as candidates for the restriction point protein. Cancer Res. 1993; 53: 1493–1497
   PubMed Web of Science ®Google Scholar
• Koff A, Giordano A, Desai D, Yamashita K, Harper J W, Elledge S, Nishimoto T, Morgan D O, Franza B R, Roberts J M. Formation and activation of a cyclin E-cdk2 complex during the Gl phase of the human cell cycle. Science 1992; 257: 1689–1694
   PubMed Web of Science ®Google Scholar
• Matsuoka M, Kato J Y, Fisher R P, Morgan D O, Sherr C J. Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase. Mol. Cell Bio. 1994; 14: 7265–7275
   PubMed Web of Science ®Google Scholar
• Matsushime H, Ewen M E, Strom D K, Kato J Y, Hanks S K, Roussel M F, Shern C J. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G cyclins. Cell 1992; 71: 323–334
   PubMed Web of Science ®Google Scholar
• Matsushime H, Quelle D E, Shurtletf S A, Shibuya M, Sherr C J, Kato J Y. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 1994; 14: 2066–2076
   PubMed Web of Science ®Google Scholar
• Meyerson M, Harlow E. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol 1994; 14: 2077–2086
   PubMed Web of Science ®Google Scholar
• Pagano M, Pepperkok R, Lukas J, Baldin V, Ansorge W, Bartek J, Draetta G. Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts. J Cell Biol 1993; 121: 101–111
   PubMed Web of Science ®Google Scholar
• Resnitzky Gossen M, Bujard H, Reed S I. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 1994; 14: 1669–1679
   PubMed Web of Science ®Google Scholar
• Tsai L, Lees E, Faha B, Harlow E, Riabowol K. The cdk2 kinase is required for the G1-to-S transition in mammalian cells. Oncogene 1993; 8: 1593–1602
   PubMed Web of Science ®Google Scholar
• Xiong Y, Zhang H, Beach D. D type cyclins associate with multiple potein kinases and the DNA replication and repair factor PCNA. Cell 1992; 71: 505–514
   PubMed Web of Science ®Google Scholar
• Morgan D O. Cell cycle control in normal and neoplastic cells. Curr. Opin. Genet. Dev. 1992; 2: 33–37
   PubMedGoogle Scholar
• Motokura T, Arnold A. cyclins and oncogenesis. Biophys. Acta 1993; 1155: 63–78
   PubMed Web of Science ®Google Scholar
• Norbury C, Nurse P. Animal cell cycles and their control. Annu. Rev. Biochem 1992; 61: 441–470
   PubMed Web of Science ®Google Scholar
• Rosenblatt J, Gu Y, Morgan D O. Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A. Proc Natl. Acad. Sci. USA 1992; 89: 2824–2828
   PubMed Web of Science ®Google Scholar
• Nasmyth K. Control of the yeast cell cycle by the Cdc 28 protein kinase. Curr Opin Cell Bio 1993; 15: 166–179
   Web of Science ®Google Scholar
• Koff A., Giordano A., Desai D., Yamashita K., Harper J. W., Elledge S., Nishimoto T., Morgan D. O. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 1992; 257: 1689–94
   PubMed Web of Science ®Google Scholar
• Weinberg R. A. The retinoblastoma protein and cell cycle control. Cell 1995; 81: 323–30
   PubMed Web of Science ®Google Scholar
• Dynlacht B. D. Regulation of transcription by proteins that control the cell cycle. Nature 1997; 389: 149–152
   PubMed Web of Science ®Google Scholar
• DeCaprio J. A., Ludlow J. W., Lynch D., Furukawa Y., Griffin J., Piwnica H., Worms Huang C. M., Livingston D. M. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 1989; 58: 1085–1095, 1989
   PubMed Web of Science ®Google Scholar
• Buchkovich K., Duffy L. A., Harlow E. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 1989; 58: 1097–1105
   PubMed Web of Science ®Google Scholar
• Chen P. P., Scully J. Y., Shew Wang J. Y., Lee W. H. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellula differentiation. Cell 1989; 58: 1193–98
   PubMed Web of Science ®Google Scholar
• Mihara K., Cao X. R., Yen A., Chandler S., Driscoll B., Amurphree L., Tang A., Fung Y K. Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 1989; 246: 1300–1303
   PubMed Web of Science ®Google Scholar
• Beijersbergen R. L., Kerkhoven R. M., Zhu L., Carlee L., Voorhoeve P. M., Bernards R. E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with pl07 in vivo. Genes Dev. 1994; 8: 2680–90
   PubMed Web of Science ®Google Scholar
• Hijmans E. M.P.M., Voorhoeve R. L., Beijersbergen L. J., Van't Veer, Bernnards R. E2F-5, a new family member that interacts with pi30 in vivo. Mol Cell Biol 1995; 15: 3080–3089
   Google Scholar
• Sardet C., Vidal M., Cobrinik D., Geng Y., Onufryk C, Chen A., Weinberg R. A. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc Natl Acad Sci USA 1995; 92: 2403–2407
   PubMedGoogle Scholar
• Vairo G., Livingston D. M., Ginsberg D. Functional interaction between E2F-4 and pi30: Evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev. 1995; 9: 869–881
   PubMed Web of Science ®Google Scholar
• Ikeda M., Jakoi L., Nevins J. R. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc Natl Acad Sci USA 1996; 93: 3215–3220
   PubMedGoogle Scholar
• Moberg K., Starz M. A., Lees J. A. E2F-4 switches from p130 to p107 and pRb in response to cell cycle reentry. Mol Cell biol 1996; 16: 1436–1449
   PubMed Web of Science ®Google Scholar
• Hurford R. K., Cobrinik D., Jr, Lee M. H., Dyson N. pRB and pl07/pl30 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev. 1997; 11: 1447–1463
   PubMed Web of Science ®Google Scholar
• Shirodkar S., Ewen M., DeCaprio J. A., Morgan J., Livingston D. M., Chittenden T. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 1992; 68: 157–166
   PubMed Web of Science ®Google Scholar
• Schwarz J. K., Devoto S. H., Smith E. J., Chellappan S. P., Jakoi L., Nevins J. R. Interactions of the pl07 and Rb proteins with E2F during the cell proliferation response. EMBO J 1993; 12: 1013–1020
   PubMed Web of Science ®Google Scholar
• Hinds P. W., Mittnacht S., Dulic V, Arnold A., Reed S. I., Weinberg R. A. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 1992; 70: 993–1006
   PubMed Web of Science ®Google Scholar
• Hiebert S. W. Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression. Mol Cell Biol 1993; 13: 338–91
   Google Scholar
• Zhu L., Van der Heuvel S., Helin K., Fattaey A., Ewen M., Livingston D. M., Dyson N., Harlow E. Inhibition of cell proliferation by pl07, a relative of the retinoblastoma protein. Genes Dev. 1993; 7: 1111–1125
   PubMed Web of Science ®Google Scholar
• Qin X-Q., Livingston D. M., Ewen M., Sellers W. R., Arany Z., Kaelin W. G., Jr. The transcription factor E2F1 is a downstream target of RB action. Mol Biol Cell 1995; 15: 742–755
   Web of Science ®Google Scholar
• Qin X-Q, Chittenden T., Livingston D. M., Kaelin W. G., Jr. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev 1992; 6: 953–964, 1992
   PubMed Web of Science ®Google Scholar
• Hannon G J, Beach D. p151NK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 1994; 371: 257–261
   PubMed Web of Science ®Google Scholar
• Kamb A, Gruis N A, Weaver-Feldhaus J, Lui O, Harshman K, Tavigian S V, Stocker E, Day R S, Johnson B E, Skolnick M H. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264: 436–440
   PubMed Web of Science ®Google Scholar
• Guan K L, Jenkins C W, Li Y, Nichols M A, Okeefe C L, Matera A G, Xiong Y. Growth suppression by pi8, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Gene & Dev 1994; 8: 2939–2952
   PubMed Web of Science ®Google Scholar
• Hirai H, Roussei M F, Kato J Y, Ashmum R A, Sherr C J. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases cdk4 and cdk6. Mol Cell Biol 1995; 15: 2672–2681
   PubMed Web of Science ®Google Scholar
• Harper J W, Admi G R, Wei N, Keymarsi K, Elledge S J. The p21 cdk-interacting protein cip is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75: 805–816
   PubMed Web of Science ®Google Scholar
• Hengst L, Dulic V, Slingerland J M, Lees E, Reed S I. A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc Natl Acad sci USA 1994; 91: 5291–5295
   PubMed Web of Science ®Google Scholar
• Polyak K, Lee M H, Bromage H E, Koff A, Roberts J M, Tempst P, Massague. Cloning of p27Kip 1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994; 78: 59–66
   PubMed Web of Science ®Google Scholar
• Toyoshima H, Hunter T. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 1994; 78: 67–74
   PubMed Web of Science ®Google Scholar
• Matsuoka S, Edwards M C, Bai C, Parker S, Zhang P, Baldini A, Harpen J W, Elledge S J. P57KIP2, a structurally distinct member of the p21CIP1 cdk inhibitor family, is a candidate tumor suppressor gene. Gene & Dev. 1995; 9: 650–662
   PubMed Web of Science ®Google Scholar
• Reynisdottir I, Polyak K, Lavarone A., Massague J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev. 1995; 9: 1831–1845
   PubMed Web of Science ®Google Scholar
• Polyak K, Kato J, Solomon M J, Sherr C J, Massague J, Roberts J M, Koff A. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 1994; 8: 9–22
   PubMed Web of Science ®Google Scholar
• Lee M H, Nikolic M, Baptista C A, Lai E, Tsai L H, Nassague J. The brain-specific activator p35 allows Cdk5 to escape inhibition by p27Kip1 in neurons. Proc Natl Acad Sci USA 1996; 93: 3259–3263
   PubMed Web of Science ®Google Scholar
• Porter P L, Malone K E, Heagerty P J, Alexander G M, Gatli L A, Firpo E J, Daling J R, Roborts J M. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat. Med. 1997; 3: 222–225
   PubMed Web of Science ®Google Scholar
• Loda M, Cukor B, Tarn S W, Lavin P, Fiorentino M, Drgetta G F, Milbum-Jessup J, Pagano M. Increased protea-some-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat. Med. 1997; 3: 231–234
   PubMed Web of Science ®Google Scholar
• Blain S W, Montalvo E. and Massague Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4. J. Bio. Chem. 1997; 272: 25863–25872
   PubMed Web of Science ®Google Scholar
• Harper J W, Elledge S J, Keyomarsi K, Dynlacht B, Tsai L H, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L, Swindell E, Fox M P, Wei N. Inhibition of cyclin-dependent kinases by p21. Mol Biol. Cell 1995; 6: 387–400
   PubMed Web of Science ®Google Scholar
• Soos T J, Kiyokawa H, Yan J S, Rubin M S, Giordano A, DeBlasio A, Bottega S, Wong B, Mendolsohn J, Koff A. Formation of p27-CDK complexes during the human mitotic cell cycle. Cell Growth Differ 1996; 7: 135–146
   PubMedGoogle Scholar
• Sporn M B, Roberts A B, Wakefield L M, Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor beta. J Cell Biol 1987; 105: 1039
   PubMed Web of Science ®Google Scholar
• Fava R A, Casey T T, Wilcox J, Pelton R W, Moses H L, Nanney L B. Synthesis of transforming growth factor-β by megakaryocytes and its location to megakaryocyte and plate-let-a granules. Blood 1990; 76: 1946
   PubMed Web of Science ®Google Scholar
• Sing G K, Keller J R, Ellingsworth L R, Ruscetti F W. Transforming growth factor-β selectively inhibits normal and leukemic human bone marrow cell growth in vitro. Blood 1988; 11: 1504–1511
   Google Scholar
• Keller J R, McNiece I K, Sill K T, Ellingsworth L R, Quesenberry P J, Ruscetti F W. Transforming growth factor-P 1 directly regulates primitive murine hematopoietic cell proliferation. Blood 1990; 75: 596–602
   PubMed Web of Science ®Google Scholar
• Ottmann O. G., Pelus L M. Differential proliferative effects of transforming growth factor-β on human hematopoietic progenitor cells. J. Immunol. 1991; 140: 2661–2665
   Google Scholar
• Snoeck H-W., Weekx S., Moulijn A., Lardon F., Lenjou M., Nys F., Van Ranst P. C.F., Van Bockstaele D. R., Berneman Z. N. Tumor necrosis factor a is a potent synergistic factor for the proliferation of primitive human hematopoietic progenitor cells and induces resistance to transforming growth factor P but not to interferon γ. J. Exp. Med. 1996; 183: 705–710
   PubMed Web of Science ®Google Scholar
• Keller J R, Jacobsen S EW, Dubois C M, Hestda I K, Ruscetti F W. Transforming growth factor-β: A bidirectional regulator of hematopoietic cell growth. Int. J. Cell Cloning 1992; 10: 2–11
   PubMedGoogle Scholar
• Sitnicka E, Ruscetti F W, Priestley G V, Wolf N S, Bartelmez S H. Transforming growth factor pi directly and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic stem cells. Blood 1996; 88: 82–88
   PubMed Web of Science ®Google Scholar
• Keller J R, Bartelmez S H, Sitnicka E, Ruscetti F W, Ortiz M, Gooya J M, Jacobsen S EW. Distinct and overlapping direct effects of macrophage inflammatory protein-1α and transforming growth factor p on hematopoietic progenitor/stem cell growth. Blood 1994; 84: 2175–2181
   PubMed Web of Science ®Google Scholar
• McNiece I K, Bertoncello I, Keller J R, Ruscetti F W, Hartley C A, Zsebo K M. Transforming growth factor P inhibits the action of stem cell factor on mouse and human hematopoietic progenitors. Int. J. Cell Cloning 1992; 10: 80–86
   PubMedGoogle Scholar
• Keller J R, Jacobsen S EW, Sill K, Ellingsworth L, Ruscetti F W. Stimulation of granulopoiesis by transforming growth factor β: Synergy with granulocyte-macrophage colony-stimulating factor. Proc. Natl. Acad. Sci. USA 1991; 88: 7190–7194
   PubMed Web of Science ®Google Scholar
• Goey H, Keller J R, Back T, Longo D L, Ruscetti F W, Wiltrout R H. Inhibition of early murine hematopoietic progenitor cell proliferation after in vivo localregional administration of transforming growth factor-β1. J Immunol 1989; 143: 877
   PubMed Web of Science ®Google Scholar
• Tessier N, Hoang T. Transforming growth factor beta inhibits the proliferation of the blast cells of acute myeloblastic leukemia. Blood 1988; 11: 159–164
   Google Scholar
• Aglietta M, Stacchini A, Severino A, Sanavio F, Ferrando M L, Piacibello W. Interaction of transforming growth factor-beta with hematopoietic growth factors in the regulation of human normal and leukemic myelopoiesis. Exp Hematol 1989; 17: 296
   PubMed Web of Science ®Google Scholar
• Cashman J D, Eaves A C, Eaves C J. Granulocyte-macrophage colony-stimulating factor modulation of the inhibitory effect of transforming growth factor-beta on normal and leukemic human hematopoietic progenitor cells. Leukemia 1992; 6: 886
   PubMed Web of Science ®Google Scholar
• Okabe-Kado J, Honma Y, Hayashi M, Hozumi M. Inhibitory action of transforming growth factor-beta on induction of differentiation of myeloid leukemia cells. Jpn J Cancer Res. 1989; 80: 228–232
   PubMedGoogle Scholar
• Kanatni Y, Kasukabe T, Okabe-Kado J, Hayashi S I, Yamamoto-Yamaguchi Y, Motoyoshi K, Nagata N, Honma Y. Transforming growth factor p and dexamethasone cooperatively enhance c-jun gene expression and inhibit the growth of human monocytoid leukemia cells. Cell Growth & Differ. 1996; 7: 187–196
   PubMedGoogle Scholar
• Furukawa Y, Uenoyama S, Ohta M, Tsunoda A, Griffin J D, Saito M. Transforming growth factor-p inhibits phosphorylation of the retinoblastoma susceptibility gene product in human monocytic leukemia cell line JOSK-I. J. Biol. Chem. 1992; 267: 17121–17127
   PubMed Web of Science ®Google Scholar
• Hu X, Lynn Moscinski C., Zuckerman K S. Transforming growth factor-p (TGFP) inhibits growth of more differentiated myeloid leukemia cells and retinoblastoma protein phosphorylation at Ser 795. Exp Hematol 1999; 27: 605–614
   PubMed Web of Science ®Google Scholar
• Cheng M, Olivier P, Diehl J A, Fero M, Roussel M F, Roberts J M, Sherr C J. The p21cip1 and p27kip1 CDK ‘inhibitors’ are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 1999; 18: 1571–1583
   PubMed Web of Science ®Google Scholar
• Koeffler H P. Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood 1983; 62: 709–721
   PubMed Web of Science ®Google Scholar